Indegene Anounces Agreement to Acquire Aptilon

IndegeneLifesystems Pvt. Ltd announced an agreement to acquire the multi-channel, video and e-detailing, and physician marketing services business of Aptilon Holdings Inc., a wholly owned subsidiary of Aptilon Corporation. Indegene Lifesystems isa leading provider of R&D, commercial and marketing solutions to top global pharmaceutical and healthcare organizations.

Aptilon, headquartered in Canada, is a pioneer and a leader in providing e-marketing solutions for several large pharmaceutical, biotech and healthcare clients in the United States, Canada and Europe. Aptilon enables clients to effectively reach, connect and interact with over 500,000 physicians and healthcare professionals via multiple access channels including iPADs, mobile and desktop media. Its innovative service and platform offerings, including Live Central and Channel HQ, provide targeted impressions and interactions through click-to-talk video and mobile detailing, digital access on-demand channels and permission-based email services that drive efficient physician recruitment and outcomes.

The pharmaceutical landscape is going through transformation. Several market forces have rendered the traditional rep-centric pharmaceutical sales model more ineffective and cost prohibitive than before. Pharmaceutical companies are focusing more of their investments and efforts on multi-channel marketing programs which promise a more effective and cost-optimized engagement with physicians. The need for intelligent, robust, and outcome-driven multi-channel marketing (MCM) and Virtual/Inside Sales programs is estimated to represent a USD 10 billion opportunity as companies continue to accelerate the transformation of their sales and marketing organizations over the next 4-5 years.


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video